FRAT J P, THILLE A W, MERCAT A, et al. High-Flow Oxygen Through Nasal Cannula in Acute Hypoxemic Respiratory Failure[J]. N Engl J Med, 2015, 372:2185-2196.
国家卫生健康委办公厅, 国家中医药管理局办公室.新型冠状病毒肺炎诊疗方案(试行第六版)[EB/OL]. (2020-02-19)[2020-03-02]. http://www.nhc.gov.cn/yzygj/s7653p/202002/8334a8326dd94d329df351d7da8aefc2.shtml.
FRAT J P, RAGOT S, GIRAULT C, et al. Effect of Non-Invasive Oxygenation Strategies in Immunocompromised Patients with Severe Acute Respiratory Failure:a Post-hoc Analysis of a Randomised Trial[J]. The Lancet Respiratory Medicine, 2016, 4(8):646-652.
LEMIALE V, RESCHE-RIGON M, MOKART D, et al. High-Flow Nasal Cannula Oxygenation in Immunocompromised Patients with Acute Hypoxemic Respiratory Failure[J]. Critical Care Medicine, 2017, 45(3):e274-e280.
AZOULAY E, LEMIALE V, MOKART D, et al. Effect of High-Flow Nasal Oxygen Vs Standard Oxygen on 28-Day Mortality in Immunocompromised Patients with Acute Respiratory Failure[J]. JAMA, 2018, 320(20):2099-2106.
FRAT J P, RICARD J D, QUENOT J P, et al. Non-invasive Ventilation Versus High-flow Nasal Cannula Oxygen Therapy with Apnoeic Oxygenation for Preoxygenation before Intubation of Patients with Acute Hypoxaemic Respiratory Failure:a Randomised, Multicentre, Open-label Trial[J]. Lancet Respir Med, 2019, 7(4):303-312.
ROCA O, CARALT B, MESSIKA J, et al. An Index Combining Respiratory Rate and Oxygenation to Predict Outcome of Nasal High-Flow Therapy[J]. American Journal of Respiratory and Critical Care Medicine, 2019, 199(11):1368-1376.